CENTURY LITHIUM PRODUCES LITHIUM HYDROXIDE AT DEMONSTRATION PLANT IN NEVADA
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company") is...
Morning Movers
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIR CRANFORD, N.J., Oct. 20, 2025 /PRNewswire/ -- Citius...
CleanSpark Announces Business Evolution from Pure-Play Bitcoin Miner to Include AI Compute; Hires Industry Veteran Jeffrey Thomas as SVP of AI Data Centers
Seasoned global executive to drive expansion into AI data center infrastructure development LAS VEGAS, Oct. 20, 2025 /PRNewswire/ -- CleanSpark, Inc....
Buscar Company Reveals Proven Reserves in NI 43-101 Technical Report Aligning with Surging Trends in Precious Metals and Critical Rare Earths
BEVERLY HILLS, Calif., Oct. 20, 2025 /PRNewswire/ -- Buscar Company (OTC: CGLD), through its wholly owned subsidiary Eon Discovery Inc.,...
Ryan Vardeman Joins LivePerson Board of Directors
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- LivePerson (Nasdaq: LPSN), a leading provider of trusted enterprise conversational AI and outcome-driven...
LightPath Technologies Receives $4.8 Million Purchase Order for Advanced Infrared Camera Systems
Purchase Order with Returning Customer to Supply IR Camera Systems for Public Safety Applications ORLANDO, Fla., Oct. 20, 2025 /PRNewswire/...
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris
ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgaris Preclinical data show production...
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Expands global intellectual property coverage in markets with high breast cancer incidence New patent will provide IP protection of Breast...
Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a...
UK Competition and Markets Authority to Refer Proposed Merger of Shutterstock and Getty Images for Phase 2 Review
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) ("Shutterstock") today received notice from the UK's Competition and...
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
TEL AVIV, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
HOLDCO ASSET MANAGEMENT ISSUES PUBLIC PRESENTATION TO THE BOARD OF DIRECTORS OF EASTERN BANKSHARES, INC.
FORT LAUDERDALE, Fla., Oct. 20, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately...
Freightos Reports KPIs for Third Quarter of 2025 Exceeding Management Expectations
The Company Plans To Report Earnings on November 17, 2025 BARCELONA, Spain, Oct. 20, 2025 /PRNewswire/ - Freightos Limited (NASDAQ:...
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population Increasing DKK1 levels further improved PFS, OS, and...
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today...
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with...
Westbridge Renewable Energy to Present at the Planet MicroCap Showcase in Toronto
CALGARY, AB, Oct. 20, 2025 /PRNewswire/ - Westbridge Renewable Energy (TSXV: WEB) (OTCQX: WEGYF) (FRA: PUQ) announced today that it...
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with...
Horizon Copper Closes Arrangement with Royal Gold
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - Horizon Copper Corp. (TSXV: HCU) (OTCQB: HNCUF) ("Horizon Copper", "Horizon", or the "Company")...
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20,...
GoldMining Reports Initial Drill Results and Confirms Multiple New Mineralized Targets across São Jorge Project, Brazil
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to report initial...
Sandstorm Gold Royalties Closes Arrangement with Royal Gold
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX:...
Nomad Foods Announces Launch of Refinancing of Senior Secured Term Loans
WOKING, England, Oct. 20, 2025 /PRNewswire/ -- Nomad Foods Limited (NYSE: NOMD) today announced the launch of an anticipated refinancing of...
IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025
83% (78/94) of patients demonstrated ocular tumor shrinkage, with 54% (51/94) achieving ≥20% tumor shrinkage 57% (24/42) eye preservation rate...
IDEAYA Biosciences Reports Positive Median Overall Survival Data from Phase 2 Trial of the Darovasertib and Crizotinib Combination in First-line Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress
Combination demonstrated median overall survival (OS) of 21.1 months, compared to reported historical mOS of approximately 12 months in published...
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up Updated Positive...
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON, Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health"...
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302...
PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive...
Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025
Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult and adolescent patients...
Nabors Energy Transition Corp. II Announces Extension of Its Outside Date
HOUSTON, Oct. 17, 2025 /PRNewswire/ -- Nabors Energy Transition Corp. II (Nasdaq: NETD) ("NETD" or the "Company") announced that its...
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in...
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended...
PodcastOne (NASDAQ: PODC) and Digital Media Giant BuzzFeed Join Forces for Original Podcast Series: Phone A Fangirl
Phone A Fangirl Sets the K-Pop World on Fire with Over 100k Plays in 24hrs, Marks First Podcast in Strategic...
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Third Coast Bancshares, Inc. Wins SCI Transaction of the Year
Award honors Third Coast's innovative synthetic risk transfer deal executed in partnership with EJF Capital HOUSTON, Oct. 17, 2025 /PRNewswire/...
SIGMA LITHIUM ADDED TO MORGAN STANLEY NATIONAL SECURITY INDEX
SÃO PAULO, Oct. 17, 2025 /PRNewswire/ -- Sigma Lithium Corporation (NASDAQ: SGML), a leading global lithium producer dedicated to powering...
SIGMA LITHIUM ADDED TO MORGAN STANLEY NATIONAL SECURITY INDEX
SÃO PAULO, Oct. 17, 2025 /PRNewswire/ -- Sigma Lithium Corporation (NASDAQ: SGML), a leading global lithium producer dedicated to powering...
Dana Incorporated to Announce 2025 Third-quarter Financial Results, Host Conference Call and Webcast on October 29
MAUMEE, Ohio, Oct. 17, 2025 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) will release its 2025 third-quarter financial results on Wednesday,...